FDA Drug Evaluation Updates - Search News

Order byBest matchMost fresh

News

FDA, Tidmarsh and Drug Administration

FDA appoints biotech veteran George Tidmarsh to lead drug evaluation division

Stanford's George Tidmarsh has authored 143 scientific papers and patents, as well as played a central role in developing seven FDA-approved drugs.

Continue reading

PharmExec · 2d

FDA Appoints George Tidmarsh as Director of Center for Drug Evaluation and Research

New head of FDA drug center is a biotech veteran and an outspoken critic of the academic establishment

1d

New medications coming soon: Here’s what’s been FDA approved in 2025 so far

GoodRx reports that in 2025, novel drug and biosimilar approvals lag slightly behind last year, while first generic approvals ...

3d

Makary ally named to key FDA drug post

Dr. George Tidmarsh, a Stanford pediatrics adjunct professor and former pharmaceutical executive, is FDA Commissioner Marty ...

25d

US FDA eliminates risk evaluation, mitigation strategies for CAR-T cancer therapies

The U.S. Food and Drug Administration said on Friday it had eliminated risk evaluation and mitigation strategies (REMS), a ...

Results that may be inaccessible to you are currently showing.

Hide inaccessible results